glp 1 anorexia nervosa GLP-1 RAs in Eating Disorders: Promising or Perilous? Treating Eating Disorder Clients Amid

GLP-1 Agonists (Semaglutide, Tirzepatide) GLP-1 receptor agonists like semaglutide and tirzepatide produce fat loss primarily through appetite suppression and reduced caloric intake rather than direct fat cell targeting

This isnt the full list of side effects for phentermine/topiramate ER

We introduce recent studies that demonstrate the remarkable performance of GLP-1RAs in slowing the progression of neurodegenerative diseases, reducing inflammation, and enhancing cardiovascular health

This modulation may underlie at least some of the observed anti-catabolic effects and improvements in fatigue-related outcomes reported in chronic disease patients receiving L-carnitine (75)

PubMed Central, Kim, Do-Kyun, et al

These considerations make thorough patient screening critical